Health and Medicine

July 24, 2014

Colon cancer’s protein signatures identified

A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer.

By Bill Snyder
July 23, 2014

Natural killer cells don’t clear HMPV

Understanding how the immune system responds to the respiratory virus HMPV is crucial for developing vaccines and anti-viral treatments.

By Leigh MacMillan
July 21, 2014

Reversing stress-induced anxiety

Augmenting the signals of natural “endocannabinoids” in the brain may be a promising approach for treating mood and anxiety disorders.

By Leigh MacMillan
One woman comforting another
July 21, 2014

Mothers of children with autism benefit from peer-led intervention: study

Peer-led interventions that target parental well-being can significantly reduce stress, depression and anxiety in mothers of children with disabilities.

By VUMC News and Communications
July 18, 2014

Neural receptor for reovirus

A newly identified receptor allows mammalian reovirus to infect neurons, shedding light on factors important for viral encephalitis.

By Leigh MacMillan
July 17, 2014

Breast tissue growth protein may promote cancer: study

A protein essential for growth of normal breast tissue also may play a role in breast cancer, Vanderbilt University researchers have found.

By Bill Snyder
July 17, 2014

Study examines therapeutic bacteria’s ability to prevent obesity

Engineered bacteria that produce a therapeutic compound in the gut prevent obesity in mice, Vanderbilt University investigators have discovered.
By Leigh MacMillan
July 17, 2014

Study identifies antibody that may fight MPV, RSV

New Vanderbilt-led research published in the Journal of Infectious Diseases has identified an antibody that shows promise in preventing and treating human metapneumovirus (MPV) and respiratory syncytial virus (RSV) — the two leading causes of respiratory infections in young children.
By Christina Echegaray
July 17, 2014

Lovly’s research bolstered by lung cancer foundation

The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology.
By VUMC News and Communications
July 17, 2014

Care for newborns with drug withdrawal uneven: study

In the United States, one infant is born each hour with drug withdrawal, known as neonatal abstinence syndrome (NAS), after being exposed to opioid medications like oxycodone in utero.
By VUMC News and Communications
July 17, 2014

VICC’s Abramson lands breast cancer clinical research award

Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF).
By VUMC News and Communications
July 17, 2014

Regulating immune regulators

Understanding how to control the generation of regulatory T cells could have important implications for treating autoimmunity and cancer.
By Leigh MacMillan
July 10, 2014

Molecular ‘chat’ holds kidney fibrosis clues

A novel molecular “conversation” regulates kidney fibrosis – the final result of end-stage chronic kidney disease – suggesting new treatment options for this currently irreversible process.
By Leigh MacMillan
1 … 138 139 140 141 142 … 197